RSV shot coverage in Newfoundland and Labrador remains limited as parents and doctors call for expansion
Parents and medical groups say Newfoundland and Labrador limits public coverage of the infant RSV antibody nirsevimab to high‑risk babies, and the province says it is examining options but has no concrete plans to expand universal coverage.
